Immuno-oncology Archives - Oncology Central Oncology Central

i
i

26 Mar 2020 Immuno-oncology
COVID-19: tocilizumab and immune checkpoint inhibitor controversies
19 Mar 2020 Targeted therapies
Pembrolizumab–niraparib response in ovarian cancer identified by novel markers
5 Mar 2020 Immuno-oncology
Prochlorperazine repurposed: a new use in clustering tumor surface receptors to support immunotherapy
17 Feb 2020 Videos
Pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices
21 Jan 2020 Immuno-oncology
Newfound killer T cell could target most cancers
14 Jan 2020 In focus: CAR-T therapy
TREM1/Dap12-based CAR-T cells show potent antitumor activity
17 Dec 2019 Clinical trials
Future Oncology: best of 2019
10 Dec 2019 Hematologic
Prior treatment with PD-1 improves safety of stem cell transplants in Hodgkin lymphoma
25 Nov 2019 Head and neck
Pembrolizumab approved as standard first-line therapy for head and neck cancer
7 Oct 2019 Opinion
Comprehensive genomic profiling: driving a new standard of cancer care
29 Sep 2019 Gynecologic
ESMO 2019 day 1 highlights: CheckMate-227 and CheckMate 067 trial results
24 Sep 2019 Spotlight on immuno-oncology
Spotlight survey on immuno-oncology